🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The researchers are testing a medication named ravulizumab for the treatmen...
Status
Recruiting
Location
Mayo Clinic Minnesota
Start Date
2026-09-01
Trial ID
NCT06333652
Treatments Being Tested
The purpose of this study was to determine the efficacy and safety of BCX99...
Status
Terminated
Location
Investigative Site
Start Date
2021-12-06
Trial ID
NCT05116774
Treatments Being Tested
This is a Phase 2/3, double-blind, randomized, placebo-controlled, parallel...
Status
Terminated
Location
Research Site
Start Date
2021-11-19
Trial ID
NCT04999020
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, pharmacoki...
Status
Completed
Location
Omeros Investigational Site
Start Date
2023-03-27
Trial ID
NCT05972967
Treatments Being Tested
The purpose of the study is to assess the efficacy and safety of ravulizuma...
Status
Terminated
Location
Barrow Neurological Institute
Start Date
2020-03-30
Trial ID
NCT04248465
Treatments Being Tested
The primary objective of this study is to evaluate pharmacokinetics (PK) of...
Status
Completed
Location
Research Site
Start Date
2019-02-19
Trial ID
NCT03748823
Treatments Being Tested
The primary purpose of this study is to assess the safety, efficacy, pharma...
Status
Completed
Location
Clinical Study Site
Start Date
2021-04-14
Trial ID
NCT04320602
Treatments Being Tested
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune conditi...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-08-01
Trial ID
NCT07010302
Treatments Being Tested
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder primarily ca...
Status
Not Yet Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2026-01
Trial ID
NCT07337395